Lactobacillus reuteri YZ-1 and application thereof
By isolating Lactobacillus reuteri YZ-1 from the intestines of zebrafish, the problems of hepatointestinal damage, Streptococcus dysgalactiae infection, and intestinal inflammation induced by high-iron feed in aquaculture were solved, achieving improvement in hepatointestinal health and enhanced resistance to pathogens.
Patent Information
- Application Number
- CN202610319701.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-17
- Publication Date
- 2026-05-15
- Estimated Expiration
- 2046-03-17
AI Technical Summary
There is a lack of comprehensive probiotics in the current technology that can simultaneously solve multiple health problems in aquaculture, such as liver and intestinal damage induced by high-iron feed, streptococcal infection, and bacterial enteritis. In particular, there are no clear reports on native probiotic strains derived from aquatic animals themselves.
A strain of Lactobacillus reuteri YZ-1, isolated from the intestine of zebrafish, was provided. It can inhibit Streptococcus faecium by reducing liver iron content and secreting specific metabolites, improve intestinal inflammation, and enhance resistance to pathogens. It can be applied to functional fish feed.
Lactobacillus reuteri YZ-1 significantly reduces iron content in the liver and intestines of fish, inhibits Streptococcus faecium, enhances resistance to Edwardsiella tarda, improves intestinal structure, reduces the expression of inflammatory factors, and alleviates liver and intestinal damage and intestinal inflammation caused by high-iron feed.